The Effect of Treatment on Mortality in Mild Hypertension

Autor: Albert Oberman, H. A. Tyroler, Reuben Berman, Joseph A. Wilber, Hilmon Castle, Glenn E. Bartsch, J. Richard Hebel, William J. Zukel, Nemato Borhani, Ro Lee, James O. Taylor, Andrew J. Lewin, Louis S. Monk, Harold W. Schnaper, Edward Filzsimons, Beth Newman, Davis Calif, Lawrence M. Slotkoff, Walter M. Kirkendall, Aristide Apostolidcs, Curtis L. Meinert, Edward H. Kass, Thomas P. Blaszkowski, Wassertheil Smoller Sylvia, M. Donald Blaufox, Sandra A. Daughcrty, John D. Abernethy, Siegfried Heyden, Flora C. Gosch, Morton H. Maxwell, Marshall Lee, Edward S. Cooper, Morton Hawkins, Curtis G. Hames, Vickie Grimes, Richard S. Crow, Herbert G. Langford, Richard H. Gadsden, Charles McCauley, Ronald J. Prineas, Roger Detels, Myra Tyler, Wallace Williams, Josephine Kastelet, Edward D. Frohlich, Jeanne Hotchkiss, Kenneth G. Berge, Kenneth A. Schneider, Richard D. Remington, Irving Ershler, J. David Curb, Max Halperin, Robert J. Hardy, Rose Stamler, Elbert Tuttle, Alvin P. Shapiro, B. Frank Polk, Agostino Molteni, Jack W. Jones, Gerald H. Payne, James Kitts, George Entwisle, McFatc Smith, David L. Sacken, Jeremiah Stamler

Publikováno v: New England Journal of Medicine. 307:976-980

In the Hypertension Detection and Follow-up Program, 7825 (71.5 per cent) of the 10,940 participants had diastolic blood pressures averaging between 90 and 104 mm Hg on entry into the study and were designated Stratum 1. Half were referred to their u

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a416309971c9a5df1028241745b0e5b8
https://doi.org/10.1056/nejm198210143071603